RHOQ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.039400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.177890E-03
Normal-vs-Stage2
1.144410E-02
Normal-vs-Stage3
8.162000E-03
Normal-vs-Stage4
2.067900E-02
Stage1-vs-Stage2
2.634800E-01
Stage1-vs-Stage3
7.236200E-01
Stage1-vs-Stage4
4.137600E-01
Stage2-vs-Stage3
5.327600E-01
Stage2-vs-Stage4
8.506800E-01
Stage3-vs-Stage4
6.807600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.643200E-03
Normal-vs-AfricanAmerican
1.454400E-01
Normal-vs-Asian
1.255650E-02
Caucasian-vs-AfricanAmerican
4.267000E-01
Caucasian-vs-Asian
1.930220E-01
AfricanAmerican-vs-Asian
2.343600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.042000E-03
Normal-vs-Female
1.090300E-02
Male-vs-Female
4.171200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.584700E-03
Normal-vs-Age(41-60Yrs)
2.518100E-02
Normal-vs-Age(61-80Yrs)
5.984500E-03
Normal-vs-Age(81-100Yrs)
1.090290E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.905990E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.113000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.396600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.064100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.939700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.722400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.321390E-03
Normal-vs-Daily Drinker
1.704030E-03
Normal-vs-Weekly Drinker
3.953600E-02
Normal-vs-Occasional Drinker
6.103200E-03
Normal-vs-Social Drinker
8.356000E-02
Non Drinker-vs-Daily Drinker
7.474000E-01
Non Drinker-vs-Weekly Drinker
9.076200E-02
Non Drinker-vs-Occasional Drinker
6.279000E-01
Non Drinker-vs-Social Drinker
7.273700E-02
Daily Drinker-vs-Weekly Drinker
7.188400E-02
Daily Drinker-vs-Occasional Drinker
4.698800E-01
Daily Drinker-vs-Social Drinker
6.208300E-02
Weekly Drinker-vs-Occasional Drinker
2.678600E-01
Weekly Drinker-vs-Social Drinker
8.855600E-01
Occasional Drinker-vs-Social Drinker
2.321000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.129200E-01
Normal-vs-Grade 2
9.404200E-01
Normal-vs-Grade 3
9.834600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.064200E-01
Grade 1-vs-Grade 3
8.254800E-01
Grade 1-vs-Grade 4
9.129200E-01
Grade 2-vs-Grade 3
1.885390E-01
Grade 2-vs-Grade 4
9.404200E-01
Grade 3-vs-Grade 4
9.834600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.284200E-02
Normal-vs-NonDiabetic
3.584700E-03
Diabetic-vs-NonDiabetic
6.971200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.340400E-02
Normal-vs-NoPancreatitis
5.760000E-03
Pancreatitis-vs-NoPancreatitis
8.991200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.840790E-03
Normal-vs-N1
1.477990E-02
N0-vs-N1
1.401430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.410170E-04
Normal-vs-TP53-NonMutant
3.143300E-03
TP53-Mutant-vs-TP53-NonMutant
5.411200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
